| PACS-2 controls endoplasmic reticulum–mitochondria communication and Bid-mediated apoptosis T Simmen, JE Aslan, AD Blagoveshchenskaya, L Thomas, L Wan, ... The EMBO journal 24 (4), 717-729, 2005 | 615 | 2005 |
| Rho GTPases in platelet function JE Aslan, OJT McCarty Journal of Thrombosis and Haemostasis 11 (1), 35-46, 2013 | 230 | 2013 |
| A physical sciences network characterization of non-tumorigenic and metastatic cells Scientific reports 3 (1), 1449, 2013 | 175 | 2013 |
| S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation JE Aslan, GW Tormoen, CP Loren, J Pang, OJT McCarty Blood 118 (11), 3129-3136, 2011 | 139 | 2011 |
| Platelet shape change and spreading. JE Aslan, A Itakura, JM Gertz, OJ McCarty Methods in molecular biology (Clifton, NJ) 788, 91, 2012 | 112 | 2012 |
| The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear CP Loren, JE Aslan, RA Rigg, MS Nowak, LD Healy, A Gruber, BJ Druker, ... Thrombosis research 135 (1), 155-160, 2015 | 81 | 2015 |
| Oral administration of Bruton's tyrosine kinase inhibitors impairs GPVI-mediated platelet function RA Rigg, JE Aslan, LD Healy, M Wallisch, MLD Thierheimer, CP Loren, ... American Journal of Physiology-Cell Physiology 310 (5), C373-C380, 2016 | 80 | 2016 |
| Akt and 14-3-3 control a PACS-2 homeostatic switch that integrates membrane traffic with TRAIL-induced apoptosis JE Aslan, H You, DM Williamson, J Endig, RT Youker, L Thomas, H Shu, ... Molecular cell 34 (4), 497-509, 2009 | 80 | 2009 |
| Phosphoproteomic quantitation and causal analysis reveal pathways in GPVI/ITAM-mediated platelet activation programs Ö Babur, AR Melrose, JM Cunliffe, J Klimek, J Pang, ALI Sepp, ... Blood, The Journal of the American Society of Hematology 136 (20), 2346-2358, 2020 | 71 | 2020 |
| Causal interactions from proteomic profiles: Molecular data meet pathway knowledge Ö Babur, A Luna, A Korkut, F Durupinar, MC Siper, U Dogrusoz, ... Patterns 2 (6), 2021 | 66 | 2021 |
| The PAK system links Rho GTPase signaling to thrombin-mediated platelet activation JE Aslan, SM Baker, CP Loren, KM Haley, A Itakura, J Pang, ... American Journal of Physiology-Cell Physiology 305 (5), C519-C528, 2013 | 64 | 2013 |
| Death by committee: organellar trafficking and communication in apoptosis JE Aslan, G Thomas Traffic 10 (10), 1390-1404, 2009 | 63 | 2009 |
| p21-Activated kinase (PAK) regulates cytoskeletal reorganization and directional migration in human neutrophils A Itakura, JE Aslan, BT Kusanto, KG Phillips, JE Porter, PK Newton, X Nan, ... PloS one 8 (9), e73063, 2013 | 61 | 2013 |
| Caught in the act–protein adaptation and the expanding roles of the PACS proteins in tissue homeostasis and disease G Thomas, JE Aslan, L Thomas, P Shinde, U Shinde, T Simmen Journal of Cell Science 130 (11), 1865-1876, 2017 | 53 | 2017 |
| The incidence, complications, and treatment of iron deficiency in pregnancy AE Benson, JJ Shatzel, KS Ryan, MA Hedges, K Martens, JE Aslan, JO Lo European journal of haematology 109 (6), 633-642, 2022 | 52 | 2022 |
| Pak2 restrains endomitosis during megakaryopoiesis and alters cytoskeleton organization RE Kosoff, JE Aslan, JC Kostyak, E Dulaimi, HY Chow, TY Prudnikova, ... Blood, The Journal of the American Society of Hematology 125 (19), 2995-3005, 2015 | 52 | 2015 |
| P21 activated kinase signaling coordinates glycoprotein receptor VI–mediated platelet aggregation, lamellipodia formation, and aggregate stability under shear JE Aslan, A Itakura, KM Haley, GW Tormoen, CP Loren, SM Baker, J Pang, ... Arteriosclerosis, thrombosis, and vascular biology 33 (7), 1544-1551, 2013 | 51 | 2013 |
| Histone deacetylase 6-mediated deacetylation of α-tubulin coordinates cytoskeletal and signaling events during platelet activation JE Aslan, KG Phillips, LD Healy, A Itakura, J Pang, OJT McCarty American Journal of Physiology-Cell Physiology 305 (12), C1230-C1239, 2013 | 48 | 2013 |
| Platelet proteomes, pathways, and phenotypes as informants of vascular wellness and disease JE Aslan Arteriosclerosis, thrombosis, and vascular biology 41 (3), 999-1011, 2021 | 44 | 2021 |
| Analysis of Adverse Events and Intravenous Iron Infusion Formulations in Adults With and Without Prior Infusion Reactions AH Arastu, BK Elstrott, KL Martens, JL Cohen, MH Oakes, ZT Rub, ... JAMA Network Open 5 (3), e224488-e224488, 2022 | 42 | 2022 |
Owen JT McCartyProfessor of Biomedical Engineering, Oregon Health & Science UniversityVerified email at ohsu.edu
